T1	Outcomes 175 191	patient outcomes
T2	Outcomes 388 410	genome-wide expression
T3	Outcomes 940 968	in progression-free survival
T4	Outcomes 1047 1070	of PTK2 gene expression
T5	Outcomes 1126 1181	PTK2 inhibition blunted R-dependent cell death in vitro
T6	Outcomes 1251 1276	increased PTK2 expression
